IL146011A0 - Adipocyte complement related protein homolog zacrp2 - Google Patents

Adipocyte complement related protein homolog zacrp2

Info

Publication number
IL146011A0
IL146011A0 IL14601100A IL14601100A IL146011A0 IL 146011 A0 IL146011 A0 IL 146011A0 IL 14601100 A IL14601100 A IL 14601100A IL 14601100 A IL14601100 A IL 14601100A IL 146011 A0 IL146011 A0 IL 146011A0
Authority
IL
Israel
Prior art keywords
zacrp2
related protein
protein homolog
complement related
adipocyte complement
Prior art date
Application number
IL14601100A
Other languages
English (en)
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Publication of IL146011A0 publication Critical patent/IL146011A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL14601100A 1999-04-20 2000-04-19 Adipocyte complement related protein homolog zacrp2 IL146011A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29507299A 1999-04-20 1999-04-20
PCT/US2000/010452 WO2000063376A1 (en) 1999-04-20 2000-04-19 Adipocyte complement related protein homolog zacrp2

Publications (1)

Publication Number Publication Date
IL146011A0 true IL146011A0 (en) 2002-07-25

Family

ID=23136091

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14601100A IL146011A0 (en) 1999-04-20 2000-04-19 Adipocyte complement related protein homolog zacrp2

Country Status (9)

Country Link
EP (1) EP1171599A1 (xx)
JP (1) JP2002541846A (xx)
AU (1) AU4468600A (xx)
CA (1) CA2370602A1 (xx)
IL (1) IL146011A0 (xx)
MX (1) MXPA01010540A (xx)
NO (1) NO20015114L (xx)
WO (1) WO2000063376A1 (xx)
ZA (1) ZA200108438B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7034132B2 (en) 2001-06-04 2006-04-25 Anderson David W Therapeutic polypeptides, nucleic acids encoding same, and methods of use
US20020155546A1 (en) * 2000-11-29 2002-10-24 Fox Brian A. Adipocyte complement related protein ZACRP12
CA2429779A1 (en) 2000-11-29 2002-08-01 Zymogenetics, Inc. Adipocyte complement related protein zacrp13

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869330A (en) * 1995-06-05 1999-02-09 Whitehead Institute For Biomedical Research DNA encoding a novel serum protein produced exclusively in adipocytes
FR2767135B1 (fr) * 1997-08-06 2002-07-12 Genset Sa Recepteur complexe lsr, activite, clonage, et application au diagnostic, a la prevention et/ou au traitement de d'obesite et des risques ou complications associes
JP2002512798A (ja) * 1998-04-29 2002-05-08 ジェネシス リサーチ アンド デベロップメント コーポレイション リミテッド 皮膚細胞から単離したポリヌクレオチドおよびその使用方法
WO1999059618A1 (en) * 1998-05-21 1999-11-25 Smithkline Beecham Corporation Acrp30r1l, a homolog of acrp30 (30 kd adipocyte complement-related protein)

Also Published As

Publication number Publication date
CA2370602A1 (en) 2000-10-26
WO2000063376A1 (en) 2000-10-26
ZA200108438B (en) 2002-08-28
EP1171599A1 (en) 2002-01-16
AU4468600A (en) 2000-11-02
NO20015114L (no) 2001-12-19
NO20015114D0 (no) 2001-10-19
MXPA01010540A (es) 2002-06-04
JP2002541846A (ja) 2002-12-10

Similar Documents

Publication Publication Date Title
GB0128994D0 (en) Peptides
GB9912998D0 (en) Depilation
IL145971A0 (en) Adipocyte complement related protein homolog zacrp3
AU2002246535A1 (en) Adipocyte complement related protein zacrp13
IL146011A0 (en) Adipocyte complement related protein homolog zacrp2
EP1147130A4 (en) ALPHA-CONOTOXIN PEPTIDES
EP1159288A4 (en) ALPHA-CONOTOXIN PEPTIDES
AU5037100A (en) Adipocyte complement related protein homolog zacrp6
GB9927681D0 (en) Protein
GB9919904D0 (en) Dressing
IL144376A0 (en) Peptides
IL150134A0 (en) Apoptin-associating protein
EP1146053A4 (en) PROTEIN MEG-4
AU2002226033A1 (en) Adipocyte complement related protein zacrp3x2
HK1045173A1 (zh) 多肽
GB0130539D0 (en) Bone marrow-specific protein
GB0112374D0 (en) Novel protein
EP1209231A4 (en) MEG-1 PROTEIN
AU2002216671A1 (en) Adipocyte complement related protein zacrp12
EP1151100A4 (en) PEPTIDES DESIGNED TAU-CONOTOXINS
GB9924060D0 (en) VIP54 protein
EP1188828A4 (en) REG-BINDING PROTEIN
AU2001297656A1 (en) Adipocyte complement related protein zacrp11
GB9918680D0 (en) Polypeptide
GB9930536D0 (en) Protein combinations